Jean Y Ko1, Van T Tong2, Jennifer M Bombard2, Donald K Hayes3, John Davy4, Katherine A Perham-Hester5. 1. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS F74, Atlanta, GA, 30341, USA. Electronic address: JeanKo@cdc.gov. 2. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS F74, Atlanta, GA, 30341, USA. 3. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS F74, Atlanta, GA, 30341, USA; Hawaii Department of Health, 714-A Sunset Avenue, Room 109, Honolulu, HI, 96816, USA. 4. Vermont Department of Health, 108 Cherry Street, Burlington, VT, 05402, USA. 5. Alaska Department of Health and Social Services, 3601C Street, Suite 358, Anchorage, AK, 99503, USA.
Abstract
BACKGROUND: We sought to describe the correlates of marijuana use during and after pregnancy, and to examine the independent relationship between prenatal marijuana use and infant outcomes. STUDY DESIGN: We used state-specific data from the Pregnancy Risk Assessment Monitoring System (N = 9013) to describe correlates of self-reported prenatal and postpartum marijuana use. We estimated differences in mean infant birth weight and gestational age among prenatal marijuana users and nonusers, controlling for relevant covariates (i.e., cigarette smoking). RESULTS: Respectively, 4.2% (95% CI: 3.8-4.7) and 6.8% (95% CI: 6.0-7.7) of women reported using marijuana during and after pregnancy. Compared to nonusers, prenatal marijuana users were more likely to be ≤24 years; non-Hispanic white, not married, have <12 years of education, have Medicaid/IHS/Other insurance, be on WIC during pregnancy, have annual household income <$20,000, cigarette smokers, and alcohol drinkers during pregnancy (p-values < 0.05). After adjustment, no differences in gestational age or birthweight were observed. Postpartum users were more likely to smoke cigarettes (48.7% vs. 20.3%), experience postpartum depressive symptoms (14.0% vs. 9.0%), and breastfeed for <8 weeks (34.9% vs. 18.1%). CONCLUSION: Co-use of substances was common among prenatal and postpartum marijuana users. Prenatal marijuana use was not independently associated with lower average birthweight or gestational age. Postpartum marijuana use was associated with depressive symptoms and shorter breastfeeding duration. Surveillance of marijuana use among pregnant and postpartum women is critical to better understanding the relationship of marijuana use with birth outcomes, and postpartum experiences such as depression and breastfeeding. Published by Elsevier B.V.
BACKGROUND: We sought to describe the correlates of marijuana use during and after pregnancy, and to examine the independent relationship between prenatal marijuana use and infant outcomes. STUDY DESIGN: We used state-specific data from the Pregnancy Risk Assessment Monitoring System (N = 9013) to describe correlates of self-reported prenatal and postpartum marijuana use. We estimated differences in mean infant birth weight and gestational age among prenatal marijuana users and nonusers, controlling for relevant covariates (i.e., cigarette smoking). RESULTS: Respectively, 4.2% (95% CI: 3.8-4.7) and 6.8% (95% CI: 6.0-7.7) of women reported using marijuana during and after pregnancy. Compared to nonusers, prenatal marijuana users were more likely to be ≤24 years; non-Hispanic white, not married, have <12 years of education, have Medicaid/IHS/Other insurance, be on WIC during pregnancy, have annual household income <$20,000, cigarette smokers, and alcohol drinkers during pregnancy (p-values < 0.05). After adjustment, no differences in gestational age or birthweight were observed. Postpartum users were more likely to smoke cigarettes (48.7% vs. 20.3%), experience postpartum depressive symptoms (14.0% vs. 9.0%), and breastfeed for <8 weeks (34.9% vs. 18.1%). CONCLUSION: Co-use of substances was common among prenatal and postpartum marijuana users. Prenatal marijuana use was not independently associated with lower average birthweight or gestational age. Postpartum marijuana use was associated with depressive symptoms and shorter breastfeeding duration. Surveillance of marijuana use among pregnant and postpartum women is critical to better understanding the relationship of marijuana use with birth outcomes, and postpartum experiences such as depression and breastfeeding. Published by Elsevier B.V.
Authors: Marleen M H J van Gelder; Jennita Reefhuis; Alissa R Caton; Martha M Werler; Charlotte M Druschel; Nel Roeleveld Journal: Drug Alcohol Depend Date: 2010-02-18 Impact factor: 4.492
Authors: Shayna N Conner; Victoria Bedell; Kim Lipsey; George A Macones; Alison G Cahill; Methodius G Tuuli Journal: Obstet Gynecol Date: 2016-10 Impact factor: 7.661
Authors: Mohammad R Hayatbakhsh; Vicki J Flenady; Kristen S Gibbons; Ann M Kingsbury; Elizabeth Hurrion; Abdullah A Mamun; Jake M Najman Journal: Pediatr Res Date: 2011-12-21 Impact factor: 3.756
Authors: Jean Y Ko; Sherry L Farr; Van T Tong; Andreea A Creanga; William M Callaghan Journal: Am J Obstet Gynecol Date: 2015-03-12 Impact factor: 8.661
Authors: Patricia Dietz; Jennifer Bombard; Candace Mulready-Ward; John Gauthier; Judith Sackoff; Peggy Brozicevic; Melissa Gambatese; Michael Nyland-Funke; Lucinda England; Leslie Harrison; Allan Taylor Journal: Matern Child Health J Date: 2014-12
Authors: Judy C Chang; Jill A Tarr; Cynthia L Holland; Natacha M De Genna; Gale A Richardson; Keri L Rodriguez; Jeanelle Sheeder; Kevin L Kraemer; Nancy L Day; Doris Rubio; Marian Jarlenski; Robert M Arnold Journal: Drug Alcohol Depend Date: 2019-01-11 Impact factor: 4.492
Authors: Suena H Massey; Daniel K Mroczek; David Reiss; Emily S Miller; Jessica A Jakubowski; Eileen K Graham; Shannon M Shisler; Meaghan McCallum; Marilyn A Huestis; Jody M Ganiban; Daniel S Shaw; Leslie D Leve; Rina D Eiden; Laura R Stroud; Jenae M Neiderhiser Journal: Neurotoxicol Teratol Date: 2018-06-07 Impact factor: 3.763